Liver Transplantation for Colorectal and Neuroendocrine Liver Metastases and Hepatoblastoma. Working Group Report from the ILTS Transplant Oncology Consensus Conference

Taizo Hibi, Mohamed Rela, James D. Eason, Pål Dag Line, John Fung, Seisuke Sakamoto, Nazia Selzner, Kwan Man, R. Mark Ghobrial, Gonzalo Sapisochin

Research output: Contribution to journalReview article

3 Scopus citations

Abstract

Liver transplantation (LT) for unresectable colorectal liver metastases has long been abandoned because of dismal prognoses. After the dark ages, advances in chemotherapy and diagnostic imaging have enabled strict patient selection, and the pioneering study from the Oslo group has contributed to the substantial progress in this field. For unresectable neuroendocrine liver metastases, LT for patients who met the Milan criteria was able to achieve excellent long-term outcomes. The guidelines further adopted in the United States and Europe were based on these criteria. For hepatoblastoma, patients with unresectable and borderline-resectable disease are considered good candidates for LT; however, the indications are yet to be defined. In the budding era of transplant oncology, it is critically important to recognize the current status and unsolved questions for each disease entity. These guidelines were developed to serve as a beacon of light for optimal patient selection for LT and set the stage for future basic and clinical studies.

Original languageEnglish (US)
Pages (from-to)1131-1135
Number of pages5
JournalTransplantation
DOIs
StatePublished - Jan 1 2020

ASJC Scopus subject areas

  • Transplantation

Fingerprint Dive into the research topics of 'Liver Transplantation for Colorectal and Neuroendocrine Liver Metastases and Hepatoblastoma. Working Group Report from the ILTS Transplant Oncology Consensus Conference'. Together they form a unique fingerprint.

  • Cite this